Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Should I Screen Website

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 3 (1)

Trial Status

Recruiting1
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05384535Not ApplicableRecruiting

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

NCT05046951Phase 3CompletedPrimary

Educating QUitline Callers About Lung Cancer Screening

NCT04786808Terminated

Risk Factors for COVID-19 Mortality

Showing all 3 trials

Research Network

Common Treatments

  • Should I Screen Website1
  • Should I Screen Print Booklet1
  • Biparametric Mri1

Active Sponsors

  • American Lung Association1
  • Northwell Health1
  • Teodoro Marcianò1
  • Georgetown University1

Related Conditions

  • Prostate Cancer1
  • Covid19 Virus Infection1
  • Acute Respiratory Distress Syndrome1
  • Magnetic Resonance Imaging1

Activity Timeline